Related references
Note: Only part of the references are listed.Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells
Zhixian Yu et al.
FASEB JOURNAL (2017)
Cancer drugs may speed tumours in some people
Heidi Ledford
NATURE (2017)
ERCC2/XPD Lys751G1n alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway
Guopei Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells
Brandon M. Hall et al.
AGING-US (2016)
Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation
Belinda Halling Sorensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6
Akihiro Yoshida et al.
CANCER RESEARCH (2016)
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Gwo Yaw Ho et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype
Nicolas Malaquin et al.
EXPERIMENTAL GERONTOLOGY (2016)
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
Justin M. David et al.
VACCINES (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Human Lung Cancer-Derived Immunosuppressive Plasmacytoid Dendritic Cells Release IL-1α in an AIM2 Inflammasome-Dependent Manner
Rosalinda Sorrentino et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Mismatch repair-dependent metabolism of O6-methylguanine-containing DNA in Xenopus laevis egg extracts
Maite Olivera Harris et al.
DNA REPAIR (2015)
Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
Verena Paulitschke et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Oxidatively induced DNA damage and its repair in cancer
Miral Dizdaroglu
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2015)
Therapy-induced tumour secretomes promote resistance and tumour progression
Anna C. Obenauf et al.
NATURE (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells
H. E. Boudreau et al.
BRITISH JOURNAL OF CANCER (2014)
Emerging trends in the epidemiology of melanoma
V. Nikolaou et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
What Is the Role of Chemotherapy in the Treatment of Melanoma?
Ahmed I. Megahed et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
Evaluation of vitamin B12 effects on DNA damage induced by paclitaxel
Karem Alzoubi et al.
DRUG AND CHEMICAL TOXICOLOGY (2014)
Thrombin-Induced CCAAT/Enhancer-Binding Protein β Activation and IL-8/CXCL8 Expression via MEKK1, ERK, and p90 Ribosomal S6 Kinase 1 in Lung Epithelial Cells
Chien-Huang Lin et al.
JOURNAL OF IMMUNOLOGY (2014)
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Grant A. McArthur et al.
LANCET ONCOLOGY (2014)
The melanoma revolution: From UV carcinogenesis to a new era in therapeutics
Jennifer A. Lo et al.
SCIENCE (2014)
Vemurafenib Induces Senescence Features in Melanoma Cells
Sebastian Haferkamp et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Meghna Das Thakur et al.
NATURE (2013)
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
Mickael Ohanna et al.
GENES & DEVELOPMENT (2011)
Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells
Valentino Bezzerri et al.
JOURNAL OF IMMUNOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inflammatory networks during cellular senescence: causes and consequences
Adam Freund et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network
Arturo V. Orjalo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis
Masayuki Sanada et al.
CARCINOGENESIS (2007)
Temozolomide induces senescence but not apoptosis in human melanoma cells
N. M. Mhaidat et al.
BRITISH JOURNAL OF CANCER (2007)
Signaling pathways regulating IL-1α-induced COX-2 expression
S. Ogata et al.
JOURNAL OF DENTAL RESEARCH (2007)
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis
Alireza Mirmohammadsadegh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
The discovery and development of cisplatin
RA Alderden et al.
JOURNAL OF CHEMICAL EDUCATION (2006)
Targeted modulation of MGMT: Clinical implications
LL Liu et al.
CLINICAL CANCER RESEARCH (2006)
Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy
J Wesierska-Gadek et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
